Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs

BACKGROUND: Baricitinib was efficacious in a 24-week phase III study in patients with rheumatoid arthritis (RA) and an inadequate response to conventional synthetic disease-modifying anti rheumatic drugs (DMARDs) (csDMARDs) (RA-BUILD). OBJECTIVES: To evaluate radiographic progression of structural j...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:RMD Open
Main Authors: van der Heijde, Desirée, Dougados, Maxime, Chen, Ying-Chou, Greenwald, Maria, Drescher, Edit, Klar, Rena, Xie, Li, de la Torre, Inmaculada, Rooney, Terence P, Witt, Sarah L, Schlichting, Douglas E, de Bono, Stephanie, Emery, Paul
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2018
Teme:
Rheumatoid Arthritis
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5950651/
https://ncbi.nlm.nih.gov/pubmed/29765703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2018-000662
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki